Neurol. praxi. 2021;22(5):422-423 | DOI: 10.36290/neu.2020.051
Cauda equina syndrome in a different light
- 1 1. lékařská fakulta Univerzity Karlovy v Praze
- 2 Neurologické oddělení Masarykova nemocnice v Ústí nad Labem, o. z., Krajská zdravotní, a. s., Ústí nad Labem
- 3 Fakulta zdravotnických studií Univerzity Jana Evangelisty Purkyně v Ústí nad Labem
We report a case of a patient with clinical symptoms resembling cauda equina syndrome, however, with a negative finding on imaging studies. Due to severe pain and progressive limb weakness, a series of examinations were performed based on which dermatomyositis was suspected. Despite intensive care and causal treatment with corticoids, the patient expired. Histopathological changes characteristic for polyarteritis nodosa were observed postmortem. Polyarteritis nodosa is a rare disease which may be neglected in the differential diagnosis for inflammatory myopathies.
Keywords: cauda equina syndrome, dermatomyositis, polyarteritis nodosa.
Received: May 18, 2020; Revised: May 29, 2020; Accepted: May 31, 2020; Prepublished online: May 31, 2020; Published: November 8, 2021 Show citation
References
- Ehler E, Zámečník J. Zánětlivé myopatie. Neurol. praxi 2012; 13(4): 204-209.
- Leclair V, Lundberg IE. New Myositis Classification Criteria - What We Have Learned Since Bohan and Peter. Curr Rheumatol Rep 2018; 20. DOI: 10.1007/s11926-018-0726-4.
Go to original source... 
Go to PubMed... - Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, Mc Shane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT. The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis & Rheumatism 2010; 33: 1088-1093. DOI: 10.1002/art.1780330805. Go to original source... Go to PubMed...
- Stanton M, Tiwari V. Polyarteritis Nodosa. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2020. http://www.ncbi.nlm.nih.gov/books/NBK482157/ (accessed 19 Mar 2020).
- Tomek A. Vaskulitidy centrálního nervového systému. Neurol. praxi 2015; 16(6): 334-339.